PT. Bio Farma Sustainability Profile
PT. Bio Farma, officially known as PT Bio Farma (Persero), is a leading biopharmaceutical company headquartered in Bandung, Indonesia. Established in 1890, it has played a pivotal role in the development and production of vaccines and sera, serving both domestic and international markets. With a strong focus on public health, Bio Farma is renowned for its high-quality vaccines, including those for hepatitis B and measles, which are vital in immunisation programmes across Indonesia and beyond. As a key player in the biopharmaceutical industry, PT. Bio Farma has achieved significant milestones, including ISO certification and recognition from the World Health Organization. Its commitment to innovation and quality has solidified its position as a trusted supplier in the global vaccine market, making it a cornerstone of Indonesia's healthcare landscape.
DitchCarbon Score
How does PT. Bio Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PT. Bio Farma's score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PT. Bio Farma's reported carbon emissions
PT. Bio Farma, headquartered in Indonesia, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. In the absence of specific emissions data or reduction initiatives, it is important to note that PT. Bio Farma is part of an industry increasingly focused on sustainability and climate commitments. Many organisations within the pharmaceutical sector are adopting science-based targets and engaging in initiatives to reduce their carbon footprints. As PT. Bio Farma continues to navigate its environmental responsibilities, it may consider aligning with industry standards and frameworks to enhance its climate strategy in the future.
How Carbon Intensive is PT. Bio Farma's Industry?
How Carbon Intensive is PT. Bio Farma's Location?
PT. Bio Farma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
PT. Bio Farma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
